LRP4-Related Congenital Myasthenic Syndrome: Clinical, Pathophysiological, and Therapeutic Aspects

Congenital Myasthenic Syndrome represents a complex and heterogeneous group of inherited neuromuscular disorders, which result from variants in genes involved in different pathophysiological mechanisms related to the neuromuscular junction. LRP4 (Low-density lipoprotein receptor-related protein 4) represents one of the most important proteins involved in this complex signaling pathway, acting in a complex with agrin and Muscle Skeletal Receptor Tyrosine Kinase (MuSK) proteins. LRP4 became known to most neurologists due to the description of anti-LRP4 antibody-related Myasthenia Gravis. There are, however, different neurological and neuromuscular disorders that result from pathogenic variants in LRP4 gene, especially a rare and potentially treatable Congenital Myasthenic Syndrome. The authors performed a detailed narrative review, including descriptions of the main pathophysiological, clinical, and therapeutic aspects of LRP4-related Congenital Myasthenic Syndromes.

Authors

Institutions

Publication Details

Journal
Muscles
Published
2026-06-24
DOI
https://doi.org/10.3390/muscles5030046
Primary Topic
Myasthenia Gravis and Thymoma
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

LRP4-Related Congenital Myasthenic Syndrome: Clinical, Pathophysiological, and Therapeutic Aspects

Sofia Mônaco Gama, Paulo Victor Sgobbi de Souza, Igor Braga Farias, Daniel Delgado Seneor et al.
Muscles
Myasthenia Gravis and Thymoma
article

LRP4-Related Congenital Myasthenic Syndrome: Clinical, Pathophysiological, and Therapeutic Aspects

Sofia Mônaco Gama, Paulo Victor Sgobbi de Souza, Igor Braga Farias, Daniel Delgado Seneor, Acary Souza Bullé Oliveira, João Paulo Barile, L García, Roberta Ismael Lacerda Machado, Wladimir Bocca Vieira de Rezende Pinto, Paulo de Lima Serrano, Sophia Luiz Calegaretti, Marcos Vinícius Martins, Renan Brandão Rambaldi Cavalheiro, Maria Júlia Tabosa de Carvalho Galvão, Mateus Medeiros Pinheiro, Felipe Yuji Koyama Azeka, Patrícia Marques Mendes, Leonardo Mobiglia Guilherme
article en

Abstract

Congenital Myasthenic Syndrome represents a complex and heterogeneous group of inherited neuromuscular disorders, which result from variants in genes involved in different pathophysiological mechanisms related to the neuromuscular junction. LRP4 (Low-density lipoprotein receptor-related protein 4) represents one of the most important proteins involved in this complex signaling pathway, acting in a complex with agrin and Muscle Skeletal Receptor Tyrosine Kinase (MuSK) proteins. LRP4 became known to most neurologists due to the description of anti-LRP4 antibody-related Myasthenia Gravis. There are, however, different neurological and neuromuscular disorders that result from pathogenic variants in LRP4 gene, especially a rare and potentially treatable Congenital Myasthenic Syndrome. The authors performed a detailed narrative review, including descriptions of the main pathophysiological, clinical, and therapeutic aspects of LRP4-related Congenital Myasthenic Syndromes.

MusclesVol. 5(3)
Universidade Estadual de Maringá (BR), Hospital Israelita Albert Einstein (BR), Faculdade de Ciências Médicas da Santa Casa de São Paulo (BR), Universidade Federal de São Paulo (BR)
Good health and well-being
Openalex Percentile: Top 6%
Myasthenia Gravis and Thymoma
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.